VivaZome and BIA Separations collaborate; VivaZome CEO presents at 2021 Biotech Showcase
  • Craig Newton
  • December 21, 2020
  • 11:38 am
  • 0 comments

BIA’s unique CIM (Convective Interaction Media) monolith chromatography technology will be used to purify exosomes from VivaZome’s cell cultures, with the aim of developing a high-efficiency downstream purification and concentration process for exosome production.  

Click to read full media release. http://vivazome.com/wp-content/uploads/2021/01/VivaZome-BIA-release-21-Dec-2020.pdf

PREVIOUSNEXT

More News

  • Craig Newton
  • November 22, 2020
  • 1:14 pm
  • 0 comments
Exosome Therapeutics: Academic Curiosity or Commercial Reality
VivaZome features in lead article in International BioPharmaceutical Industry journal. “Exosome Therapeutics: Academic Curiosity or Commercial Reality” written by VivaZome CEO David Haylock and key academic collaborator Prof Andy Hill (La Trobe Uni).  Click here to read article: 2020-IBI_Summer-Vivazome
READ MORE
  • Craig Newton
  • June 26, 2020
  • 5:46 pm
  • 0 comments
VivaZome in the spotlight as Precinct Partner at La Trobe University
VivaZome’s David Haylock says his company’s decision to base themselves in the Research & Innovation Precinct at La Trobe University revolved largely around one key researcher. Read the full story here  https://www.latrobe.edu.au/industry-and-community/industry-partner-of-choice/research-and-innovation-precinct/precinct-partner-spotlight/vivazome
READ MORE
  • Craig Newton
  • June 20, 2020
  • 5:54 pm
  • 0 comments
VivaZome features in “Inspire”
VivaZome features in “Inspire” – Research Australia’s Showcase for Health and Medical Research and Innovation.  Download the article here: INSPIRE_20Jun2020
READ MORE